Zakład Anatomopatologiisp. z o.o.

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2014-07-09
Share capital
50,000.00 PLN
Registered address
Warszawska 14, 96-200 Rawa Mazowiecka, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2021 – the filing deadline has passed. 1 of 3 financial statements was filed late (for 2019, 348 days late).

  • 2021not filed
  • 202028/09/2021
  • 201928/09/2021
  • 201818/06/2019
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2020.

Industry · Human health activities9 / 12
Top 75%
Division · Human health activities7,059 / 7,730
Top 91%
Top 89%
Voivodeship · Łódzkie18,333 / 23,391
Top 78%
Country · Poland382,824 / 495,860
Top 77%

Results vs industry

Revenue
This companyUSD 21.16kMedianUSD 274.62kAverageUSD 319.38k
Net profit
This companyUSD 1.72kMedianUSD 2.02kAverageUSD 5.49k
Operating costs
This companyUSD 19.26kMedianUSD 262.99kAverageUSD 311.01k
Assets
This companyUSD 38.66kMedianUSD 69.35kAverageUSD 125.50k

Authorized Representatives

Adam Kopczyński – President of the Management Board

Manner of representation

Each member of the management board is authorised to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
Adam Marek Sondkaage 51
95$12,830.9095%
Others
5$675.315%

Beneficial owners

Person

Bank accounts

Was a VAT taxpayer from 2014-07-09 to 2023-04-04.

Reason for removal: Art. 96 ust. 9a pkt 2 (VAT returns not filed for 3 consecutive months or a quarter)

Debt

No entries in the National Debtors Register (KRZ).

MSiG notices

Publication dateEvent
Sep 17, 2021Dissolution without liquidation opened

Public aid

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$1,913
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$2,912

Competitors

FAQ

Last updated: 2026-04-08